[HTML][HTML] The epidemiology of Alzheimer's disease modifiable risk factors and prevention
XX Zhang, Y Tian, ZT Wang, YH Ma, L Tan… - The journal of prevention …, 2021 - Springer
Mild Alzheimer's disease is the leading cause of dementia, accounting for 50–70% of cases.
Alzheimer's disease is an irreversible neurodegenerative disease, which affects daily life …
Alzheimer's disease is an irreversible neurodegenerative disease, which affects daily life …
[HTML][HTML] Mechanisms and treatment of late-life depression
GS Alexopoulos - Translational psychiatry, 2019 - nature.com
Depression predisposes to medical illnesses and advances biological aging indicated by
shorter telomere length, accelerated brain aging and advanced epigenetic aging. Medical …
shorter telomere length, accelerated brain aging and advanced epigenetic aging. Medical …
Dementia prevention, intervention, and care
Executive summary Acting now on dementia prevention, intervention, and care will vastly
improve living and dying for individuals with dementia and their families, and in doing so …
improve living and dying for individuals with dementia and their families, and in doing so …
[HTML][HTML] Depression—an underrecognized target for prevention of dementia in Alzheimer's disease
FS Dafsari, F Jessen - Translational Psychiatry, 2020 - nature.com
It is broadly acknowledged that the onset of dementia in Alzheimer's disease (AD) may be
modifiable by the management of risk factors. While several recent guidelines and …
modifiable by the management of risk factors. While several recent guidelines and …
Considering sex and gender in Alzheimer disease and other dementias
JL Podcasy, CN Epperson - Dialogues in clinical neuroscience, 2016 - Taylor & Francis
Suffering related to dementia is multifaceted because cognitive and physical functioning
slowly deteriorates. Advanced age and sex, two of the most prominent risk factors for …
slowly deteriorates. Advanced age and sex, two of the most prominent risk factors for …
[HTML][HTML] GABAergic inhibitory interneuron deficits in Alzheimer's disease: implications for treatment
Y Xu, M Zhao, Y Han, H Zhang - Frontiers in neuroscience, 2020 - frontiersin.org
Alzheimer's disease (AD) is a neurodegenerative disorder characterized clinically by severe
cognitive deficits and pathologically by amyloid plaques, neuronal loss, and neurofibrillary …
cognitive deficits and pathologically by amyloid plaques, neuronal loss, and neurofibrillary …
[HTML][HTML] Review of the neurological benefits of phytocannabinoids
J Maroon, J Bost - Surgical neurology international, 2018 - ncbi.nlm.nih.gov
Background: Numerous physical, psychological, and emotional benefits have been
attributed to marijuana since its first reported use in 2,600 BC in a Chinese pharmacopoeia …
attributed to marijuana since its first reported use in 2,600 BC in a Chinese pharmacopoeia …
Cannabidiol, neuroprotection and neuropsychiatric disorders
Cannabidiol (CBD) is a non-psychotomimetic phytocannabinoid derived from Cannabis
sativa. It has possible therapeutic effects over a broad range of neuropsychiatric disorders …
sativa. It has possible therapeutic effects over a broad range of neuropsychiatric disorders …
[HTML][HTML] The role of serotonin within the microbiota-gut-brain axis in the development of Alzheimer's disease: A narrative review
E Aaldijk, Y Vermeiren - Ageing Research Reviews, 2022 - Elsevier
Alzheimer's disease (AD) is the most common cause of dementia, accounting for more than
50 million patients worldwide. Current evidence suggests the exact mechanism behind this …
50 million patients worldwide. Current evidence suggests the exact mechanism behind this …
[HTML][HTML] Chronic stress and glucocorticoids: from neuronal plasticity to neurodegeneration
Stress and stress hormones, glucocorticoids (GCs), exert widespread actions in central
nervous system, ranging from the regulation of gene transcription, cellular signaling …
nervous system, ranging from the regulation of gene transcription, cellular signaling …